Bank of America’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23B | Buy |
7,259,501
+707,343
| +11% | +$121M | 0.09% | 215 |
|
|
2025
Q4 | $1.11B | Buy |
6,552,158
+658,317
| +11% | +$107M | 0.08% | 231 |
|
|
2025
Q3 | $851M | Sell |
5,893,841
-243,108
| -4% | -$33.2M | 0.06% | 301 |
|
|
2025
Q2 | $776M | Sell |
6,136,949
-830,457
| -12% | -$102M | 0.06% | 319 |
|
|
2025
Q1 | $891M | Sell |
6,967,406
-522,021
| -7% | -$70.8M | 0.07% | 267 |
|
|
2024
Q4 | $990M | Buy |
7,489,427
+336,854
| +5% | +$47.4M | 0.08% | 236 |
|
|
2024
Q3 | $1.04B | Sell |
7,152,573
-367,544
| -5% | -$53.2M | 0.08% | 240 |
|
|
2024
Q2 | $1.03B | Sell |
7,520,117
-114,023
| -1% | -$15.2M | 0.09% | 227 |
|
|
2024
Q1 | $1.05B | Sell |
7,634,140
-792,218
| -9% | -$108M | 0.1% | 223 |
|
|
2023
Q4 | $1.14B | Sell |
8,426,358
-1,253,055
| -13% | -$153M | 0.12% | 189 |
|
|
2023
Q3 | $1.18B | Sell |
9,679,413
-1,483,329
| -13% | -$189M | 0.13% | 165 |
|
|
2023
Q2 | $1.42B | Sell |
11,162,742
-87,249
| -0.8% | -$11.3M | 0.15% | 148 |
|
|
2023
Q1 | $1.45B | Buy |
11,249,991
+1,524,684
| +16% | +$200M | 0.15% | 145 |
|
|
2022
Q4 | $1.28B | Sell |
9,725,307
-382,425
| -4% | -$49.4M | 0.15% | 155 |
|
|
2022
Q3 | $1.18B | Sell |
10,107,732
-1,045,093
| -9% | -$130M | 0.14% | 152 |
|
|
2022
Q2 | $1.31B | Sell |
11,152,825
-1,178,761
| -10% | -$140M | 0.15% | 144 |
|
|
2022
Q1 | $1.61B | Buy |
12,331,586
+662,732
| +6% | +$86.3M | 0.16% | 125 |
|
|
2021
Q4 | $1.78B | Sell |
11,668,854
-230,870
| -2% | -$35.7M | 0.17% | 121 |
|
|
2021
Q3 | $1.92B | Sell |
11,899,724
-341,190
| -3% | -$57.4M | 0.2% | 106 |
|
|
2021
Q2 | $2B | Sell |
12,240,914
-1,300,625
| -10% | -$200M | 0.21% | 104 |
|
|
2021
Q1 | $2.04B | Sell |
13,541,539
-183,906
| -1% | -$29.2M | 0.23% | 95 |
|
|
2020
Q4 | $2.08B | Buy |
13,725,445
+156,190
| +1% | +$22.3M | 0.27% | 93 |
|
|
2020
Q3 | $1.84B | Buy |
13,569,255
+1,051,660
| +8% | +$143M | 0.25% | 96 |
|
|
2020
Q2 | $1.71B | Sell |
12,517,595
-1,235,703
| -9% | -$158M | 0.26% | 97 |
|
|
2020
Q1 | $1.48B | Sell |
13,753,298
-1,254,932
| -8% | -$144M | 0.27% | 100 |
|
|
2019
Q4 | $1.81B | Sell |
15,008,230
-1,855,023
| -11% | -$207M | 0.26% | 94 |
|
|
2019
Q3 | $1.68B | Sell |
16,863,253
-465,270
| -3% | -$48.7M | 0.25% | 96 |
|
|
2019
Q2 | $1.89B | Buy |
17,328,523
+2,867,408
| +20% | +$305M | 0.29% | 85 |
|
|
2019
Q1 | $1.62B | Buy |
14,461,115
+1,360,157
| +10% | +$149M | 0.25% | 93 |
|
|
2018
Q4 | $1.26B | Sell |
13,100,958
-968,255
| -7% | -$103M | 0.22% | 102 |
|
|
2018
Q3 | $1.72B | Sell |
14,069,213
-457,580
| -3% | -$53.9M | 0.27% | 81 |
|
|
2018
Q2 | $1.6B | Buy |
14,526,793
+638,597
| +5% | +$68.3M | 0.26% | 86 |
|
|
2018
Q1 | $1.48B | Buy |
13,888,196
+267,897
| +2% | +$29.7M | 0.25% | 94 |
|
|
2017
Q4 | $1.45B | Buy |
13,620,299
+45,764
| +0.3% | +$4.89M | 0.24% | 101 |
|
|
2017
Q3 | $1.51B | Buy |
13,574,535
+8,690,961
| +178% | +$929M | 0.24% | 105 |
|
|
2017
Q2 | $505M | Sell |
4,883,574
-951,375
| -16% | -$93.7M | 0.1% | 219 |
|
|
2017
Q1 | $570M | Buy |
5,834,949
+169,743
| +3% | +$16.3M | 0.11% | 186 |
|
|
2016
Q4 | $501M | Sell |
5,665,206
-871,455
| -13% | -$79.3M | 0.11% | 206 |
|
|
2016
Q3 | $631M | Sell |
6,536,661
-1,211,949
| -16% | -$115M | 0.14% | 166 |
|
|
2016
Q2 | $665M | Buy |
7,748,610
+926,940
| +14% | +$83.2M | 0.15% | 152 |
|
|
2016
Q1 | $593M | Buy |
6,821,670
+1,266,864
| +23% | +$113M | 0.14% | 165 |
|
|
2015
Q4 | $626M | Sell |
5,554,806
-315,843
| -5% | -$34.3M | 0.15% | 150 |
|
|
2015
Q3 | $594M | Buy |
5,870,649
+2,483,139
| +73% | +$298M | 0.15% | 153 |
|
|
2015
Q2 | $417M | Sell |
3,387,510
-1,164,954
| -26% | -$139M | 0.14% | 163 |
|
|
2015
Q1 | $521M | Buy |
4,552,464
+141,711
| +3% | +$15.6M | 0.18% | 131 |
|
|
2014
Q4 | $446M | Buy |
4,410,753
+548,907
| +14% | +$53.3M | 0.16% | 137 |
|
|
2014
Q3 | $352M | Sell |
3,861,846
-213,435
| -5% | -$18.7M | 0.11% | 193 |
|
|
2014
Q2 | $349M | Buy |
4,075,281
+142,263
| +4% | +$11.2M | 0.11% | 192 |
|
|
2014
Q1 | $310M | Sell |
3,933,018
-429,156
| -10% | -$35.8M | 0.12% | 197 |
|
|
2013
Q4 | $330M | Buy |
4,362,174
+693,918
| +19% | +$49.2M | 0.12% | 190 |
|
|
2013
Q3 | $256M | Sell |
3,668,256
-23,865
| -0.6% | -$1.56M | 0.1% | 203 |
|
|
2013
Q2 | $214M | Buy |
+3,692,121
| New | +$213M | 0.09% | 205 |
|
Other funds holding IBB
CB
Bank of America's IBB Position: Q1 2026 in Review
Bank of America increased its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2026, buying an estimated $121M and bringing the position to 7,259,501 shares worth $1.23B. The position accounts for 0.09% of the portfolio, ranked #215.
Bank of America first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08B in Q4 2020. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Bank of America held 7,259,501 shares of iShares Biotechnology ETF worth $1.23B as of Q1 2026.
- Bank of America bought 707,343 iShares Biotechnology ETF shares in Q1 2026, an estimated $121M.
- iShares Biotechnology ETF made up 0.09% of Bank of America's portfolio in Q1 2026, its #215 holding.
- Bank of America first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of America's iShares Biotechnology ETF position peaked at $2.08B in Q4 2020.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.